-
Expert Rev Anticancer Ther · Apr 2015
EditorialNew insights into the molecular profile of lung adenocarcinoma and implications for therapy.
- Bharath Ganesh, Siddhartha Devarakonda, and Ramaswamy Govindan.
- 1 Division of Medical Oncology, Washington University School of Medicine in St. Louis, 660 S. Euclid, Box 8056, St. Louis, MO 63021, USA.
- Expert Rev Anticancer Ther. 2015 Apr 1;15(4):361-4.
AbstractLung cancer is a molecularly heterogeneous disease. The advent of next-generation sequencing techniques has significantly advanced our understanding of the complex molecular underpinnings of lung cancer. Furthermore, the development of targeted therapies has significantly altered the landscape of lung cancer therapy over the past decade. There is hence an increasing interest in developing a classification system that guides clinical management and also incorporates relevant genomic information. Here, we highlight the molecular features of lung adenocarcinoma as highlighted by several independent groups, and more recently The Cancer Genome Atlas and discuss their potential clinical significance.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..